Cipla Health forays into consumer skincare by launching Rivela Dermascience – A Science Backed Skincare Brand
Developed by Scientists, Evaluated by Dermatologists, the brand has developed a line of products that caters to the skincare concerns of the Indian consumers
March 17, 2023
In an attempt to cater to the evolving skincare needs of the discerning consumers, Cipla Health Limited (CHL), pioneers in driving innovation and simplifying healthcare by addressing unmet consumer needs, recently launched Rivela Dermascience for the Indian Skincare Industry. Backed by the power of science & expertise of dermatologists, Rivela Dermascience brings together Cipla’s legacy of trust and care with the ever-evolving advancements in dermatological research. Offering a range of 14 SKUs the brand provides products for specific consumer needs. The products range from cleanser, toner, serums, moisturiser, eye care to sunscreen.
Rivela Dermascience products are dermatologically tested on Indian skin in leading labs in the country for their efficacy and safety against any allergies, reactions or inflammations. These clinical tests are conducted under standardised protocols and under the guidance of dermatologists, as the brand is focused on providing safe products for their consumers.
Developed by experts, the brand revolves around providing the right ingredients as per the skincare needs of the Indian consumers. To enable ultimate consumer experiential satisfaction, the website (www.riveladermascience.com) offers a free skin assessment for the consumers to identify the products that could be suitable to their skincare requirements. The products are paraben free, SLS free, mineral oil free and cruelty free as they are not tested on animals.
Speaking about the launch, Mr. Shivam Puri, Chief Executive Officer, Cipla Health Ltd. said, “We at Cipla Health are elated to introduce Rivela Dermascience, a brand which enables us to provide consumers with a clean and effective product line. Guided by Cipla’s scientific acumen, the products are designed to be very ingredient specific and hence result oriented. Our path-breaking technological innovations and research, will provide the necessary solution driven skincare products for all the skincare needs of our consumers across the country.”
|
|
|
Cipla Ltd
March 17, 2023
Need good help?
Check out our Services
Press Release Distribution & Writing Services
More News From Cipla Ltd
- First approved allogeneic cell therapy product globally for the treatment of CLI - Developed by Stempeutics over a period of twelve years, breakthrough treatment designed to address root cause of the disease at an ...
Similar News
Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global pharmaceuticals company has received final approval by the United States Food & Drug Administration (U.S. FDA) for Calcipotriene and ...
